Merrimack Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch MACK and buy or sell other stocks, ETFs, and their options commission-free!

About MACK

Merrimack Pharmaceuticals discovers, designs, and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. Their systems biology is to apply capabilities to build functional and predictive computational models of biological systems such as cell signaling networks.

CEO

Gary L. Crocker, MBA

CEOGary L. Crocker, MBA

Employees

—

Employees—

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1993

Founded1993

Employees

—

Employees—

MACK Key Statistics

Market cap

219.87M

Market cap219.87M

Price-Earnings ratio

-8.91

Price-Earnings ratio-8.91

Dividend yield

—

Dividend yield—

Average volume

515.00K

Average volume515.00K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$15.89

52 Week high$15.89

52 Week low

$11.53

52 Week low$11.53